The Pathophysiology of Gestational Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 163 of the 175 references it cites were found in a registry or an index; 42 of the 157 sources its claims cite were checked for support.
Abstract
Review of risk factors and maternal and child consequences of gestational diabetes mellitus.
Overview
CoChat Summary
TL;DR
This review summarizes the proposed pathophysiology of gestational diabetes mellitus (GDM), emphasizing that most cases involve β-cell dysfunction on a background of chronic insulin resistance. It argues that genetic, epigenetic, environmental, placental, inflammatory, oxidative, and microbiome-related factors likely interact, but the molecular mechanisms remain incompletely defined.
Key findings
- GDM affects approximately 14% of pregnancies worldwide according to 2017 IDF estimates, representing about 18 million births annually; the abstract also states approximately 16.5% worldwide.
- The review states that the vast majority (~80%) of GDM cases present as β-cell dysfunction on a background of chronic insulin resistance.
- In GDM, the rate of insulin-stimulated glucose uptake is reduced by 54% compared with normal pregnancy.
- The paper reports several outcome estimates: ~60% of women with prior GDM develop T2DM later in life, the yearly conversion risk is ~2 to 3%, and one study found a 63% increased risk of CVD among women with a history of GDM.
Methods
- This is a narrative review of the pathophysiology of GDM; it does not present a new experimental or clinical study.
- The paper synthesizes previously published evidence on glucose regulation in pregnancy, classification/prevalence, risk factors, consequences, and molecular mechanisms across tissues and systems.
- The analysis is descriptive and integrative, drawing on cited studies, including epidemiological studies, animal studies, mechanistic studies, and large cohort findings such as the HAPO Study (23,000 pregnant women).
Limitations
- The paper explicitly notes that epidemiological studies of risk factors for GDM are limited and typically afflicted by confounding factors, and that inconsistencies in diagnostic criteria and risk-factor measurement make studies hard to compare.
- The review states that molecular mechanisms underlying GDM are poorly defined and that greater understanding is required to develop effective treatments and prevention strategies.
- It is evident from the text that this is not an original empirical study, so it cannot establish causal effects on its own; it relies on secondary synthesis of heterogeneous prior literature.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
40 Valid · 2 Not valid · 86 Not checked · 24 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This loss of β-cell mass has been linked to epigenetic downregulation of pancreatic homeobox transcription factor (Pdx1), which is essential for normal β-cell differentiation in the embryo [79].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [79] Pinney, 2010, Epigenetic mechanisms in the development of type 2 diabetes, Trends Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The ‘Chromatin Remodeling in the β-cell of IUGR rats’ section reports epigenetic repression of Pdx-1 in growth-restricted rats and describes its critical role in pancreatic development and β-cell differentiation. It does not link that repression to a loss of β-cell mass; it instead discusses β-cell secretory dysfunction, and notes that a milder Pdx-1 reduction in mice permits normal β-cell mass. Page numbers were not available in our copy. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Partly supportedcites [75] Prentki, 2006, Islet beta cell failure in type 2 diabetes, J. Clin. Investig. sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) proposes that one or a small number of β-cell defects can become weak links when β-cells must compensate for insulin resistance. That supports the general idea of deficiencies becoming consequential under increased demand. The review-series passage mentioning pregnancy (page unavailable) instead discusses maternal hyperglycemia as a risk factor for the offspring; it does not say pregnancy exposes a pre-existing β-cell deficiency in the pregnant person. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In addition, glucotoxicity is also thought to result in β-cell apoptosis over time [76].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 2. Pathophysiology of Gestational Diabetes > 2.1. β-Cell Dysfunction
What the sources say
- Supportedcites [76] Ashcroft, 2017, Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?, Cell MeTable source
The Abstract states that elevated plasma glucose leads to β-cell dysfunction and death and describes glycogen accumulation as contributing to this ‘glucotoxicity.’ The section ‘An Emerging Role for Glycogen in the Pathophysiology of Diabetes’ reports increased apoptosis in mouse β-cells with substantial glycogen stores. It qualifies the mechanism: apoptosis appears to result from glycogen accumulation rather than elevated glucose alone. Page numbers were not available in our copy. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While potentially beneficial in times of famine, a mismatch between nutritional status in the womb and nutritional status once born can contribute to the development of obesity and metabolic disease [53,54].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Not checked — no full text of the sourcecites [53] Vickers, 2000, Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition, Am. J. Physiol. Endocrinol. MeTable source
- Supportedcites [54] Desai, 2014, Maternal obesity and high-fat diet program offspring metabolic syndrome, Am. J. Obstet. Gynecol. source
The Methods (The Offspring; page not provided) describe groups with different high-fat-diet exposures during pregnancy and lactation, including both mismatched combinations. The Discussion (page not provided) reports increased offspring adiposity or obesity and metabolic disturbances in these groups. This supports the attributed claim that a prenatal–postnatal nutritional mismatch can contribute to obesity and metabolic disease. (LLM, conf=0.90)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These individuals are more likely to have experienced hyperglycemia and β-cell fatigue even before birth, predisposing them to hyperglycemia during times of later metabolic stress, such as during pregnancy [55].”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction > 1.4. Risk Factors for Gestational Diabetes
What the sources say
- Partly supportedcites [55] Portha, B., Chavey, A., and Movassat, J. (2011). Early-Life Origins of Type 2 Diabetes: Fetal Programming of the Beta-Cell Mass. Exp. Diabetes Res., 2011. sourceExperimental — accuracy not yet measured
Section 4 (page unavailable) links early-life stressors, including maternal overnutrition, to later endocrine pancreatic deficiency and says pregnancy can expose a latent low insulin response in female offspring. It also describes hyperglycemia during fetal and/or early postnatal life. The copy does not establish that overnourished individuals experienced β-cell fatigue before birth; the discussion relies substantially on animal models and does not isolate prenatal exposure for every case. (LLM, conf=0.84)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
81 more claims · 18 with their cited sources checked
Create a free account to see all 152 claims and to verify the 30 references still open.
- Probably not a substantial claim. 19
- It may state two separate claims as one. 54
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mechanisms of β-cell hypertrophy and proliferation, resulting in a 300% increase in insulin secretion in the first two trimesters of physiological pregnancy, is insufficient to explain GDM [9,39].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Despite numerous studies, the pathogenesis of GDM remains unclear, and the results obtained so far indicate a complex mechanism of interaction of many genetic, metabolic and environmental factors [9].”
From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [9]
In the citing paper
“Under GDM, maternal insulin resistance increases the flux of glucose to the fetal circulation and contributes to increased fetal glucose uptake and growth [8].”
From Evaluating Traditional Chinese Medicine and Herbal Products for the Treatment of Gestational Diabetes Mellitus (2019) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“In most cases, this hyperglycemia is the result of impaired glucose tolerance due to pancreatic β-cell dysfunction on a background of chronic insulin resistance.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 4. Conclusions
“in the majority of cases, pancreatic β-cells fail to compensate for a chronic fuel surfeit, leading to eventual insulin resistance, hyperglycemia, and an increased supply of glucose to the growing fetus.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The Pathophysiology of Gestational Diabetes Mellitus > Abstract
“GDM affects approximately 16.5% of pregnancies worldwide, and this number is set to increase with the escalating obesity epidemic.”
§ The Pathophysiology of Gestational Diabetes Mellitus > 1. Introduction
“According to the most recent (2017) International Diabetes Federation (IDF) estimates, GDM affects approximately 14% of pregnancies worldwide, representing approximately 18 million births annually [2].”
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Both red meat and animal protein decrease levels of Firmicutes, while high dietary fiber increase them [133].”
BackgroundChanges of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277 · cited 1×
“Increased gut permeability is thought to facilitate the movement of inflammatory mediators from the gut into the circulation, promoting systemic insulin resistance [134,136].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Adiponectin enhances insulin signaling and fatty acid oxidation, and it inhibits gluconeogenesis [104].”
Backgroundβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s002 · Cited by 3,159
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Non-diabetic obese individuals exhibit adequate adipose tissue expansion in response to fuel surfeit, and therefore maintain healthy blood glucose concentrations, sufficient β-cell compensation, and avoid chronic insulin resistance [110,111].”
Background
Research works printed but not linked: 1
- Halliwell, B., and Gutteridge, J. (2007). Free Radicals in Biology and Medicine, Oxford University Press. [4th ed.].
Cited by
Items 201–300 of 1,810
Yavuzkır, Ş., Uğur, K., Deniz, R., Üstebay, D. Ü., Mirzaoglu, M., Yardım, M., Şahin, İ., Baykuş, Y., Karagöz, Z. K., & Aydın, S. (2020) · Peptides · doi:10.1016/j.peptides.2020.170277 · Cited by 30
Zhang, L., Yin, W., Yu, W., Wang, P., Wang, H., Zhang, X.-J., & Zhu, P. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.163521 · Cited by 31
Faienza, M. F., Urbano, F., Anaclerio, F., Moscogiuri, L. A., Konstantinidou, F., Stuppia, L., & Gatta, V. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050265 · Cited by 32
“…obesity stimulate fetal insulin secretion, and several anabolic processes such as lipogenesis, protein synthesis, and fetal glucose consumption in insulin-sensitive cells as hepatocytes, myocytes, adipocytes, causing expanded fetal growth, increasing glucose requests and IR in late gestation [62].”
BackgroundAdipokines in Pregnancy: A Systematic Review of Clinical Data
Kabbani, N., Blüher, M., Stepan, H., Stümvoll, M., Ebert, T., Tönjes, A., & Schrey-Petersen, S. (2023) · Biomedicines · doi:10.3390/biomedicines11051419 · Cited by 34
“This phenomenon is physiologically countered through hypertrophy or hyperplasia of the pancreatic β-cells and subsequently elevated insulin secretion [1].”
BackgroundGestational Diabetes Mellitus: What Can Medical Nutrition Therapy Do?
Wei, X., Zou, H., Zhang, T., Huo, Y., Yang, J., Wang, Z., Li, Y., & Zhao, J. (2024) · Nutrients · doi:10.3390/nu16081217 · Cited by 37
Suwaydi, M. A., Wlodek, M. E., Lai, C. T., Prosser, S. A., Geddes, D. T., & Perrella, S. L. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04685-0 · Cited by 33
“Furthermore, GDM may impact the lifetime risk of offspring, fuelling a vicious circle of offspring obesity, impaired glucose metabolism, and metabolic syndrome that contribute to the subsequent development of T2D later in life [3, 4].”
BackgroundFang, C., Gan, Y., Li, Y., He, W., Wu, W., Wang, K., & Li, Q. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02207-0 · Cited by 30
“, cardiovascular, obesity and type 2 diabetes) for the mother and the offspring [3, 4].”
BackgroundVisiedo, F., Vázquez-Fonseca, L., Ábalos-Martínez, J., Broullón, J. R., Quintero‐Prado, R., Mateos, R. M., & Bugatto, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1146574 · Cited by 30
“This proinflammatory status may directly influence placental development and function from the onset of GDM (5, 6), and further may indirectly influence fetal metabolic programming for later disease (7, 8).”
BackgroundTaliento, C., Piccolotti, I., Sabattini, A., Tormen, M., Cappadona, R., Greco, P., & Scutiero, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082198 · Cited by 43
“Moreover, in [36], they were found to share similar pathophysiological mechanisms that included inflammation, vascular dysfunction, oxidative stress, and vascular disease.”
BackgroundLiu, W., Gao, M., Yang, S., Sun, C., Bi, Y., Li, Y., Wang, J., & Yuan, X. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108451 · Cited by 26
Chan, Y.-N., Wang, P., Chun, K.-H., Lum, J. T.-S., Wang, H., Zhang, Y., & Leung, K. S. (2023) · Scientific Reports · doi:10.1038/s41598-023-31270-y · Cited by 29
“); (3) did not smoke or drink alcohol.”
BackgroundYang, J., Wang, J., Wu, W., Su, C., Wu, Y., & Li, Q. (2024) · Food & Function · doi:10.1039/d3fo04681h · Cited by 29
Gestational Diabetes Mellitus: The Genetic Susceptibility Behind the Disease
Wei, W., He, Y., Wang, X., Tan, G., Zhou, F., Zheng, G., Tian, D., Ma, X., & Yu, H. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1546-1652 · Cited by 32
“In general, pregnant women are physiologically hyperglycemic [7], and a hyperglycemic environment is associated with oxidative stress [6].”
BackgroundInfluentialInflammation in Pregnancy: Key Drivers, Signaling Pathways and Associated Complications
García-Morales, A., Lomas‐Soria, C., Granados-Higa, G., García‐Quiroz, J., Avila, E., Olmos‐Ortiz, A., & Díaz, L. (2025) · Archives of Medical Research · doi:10.1016/j.arcmed.2025.103301 · Cited by 36
Pregnancy-associated cardiac dysfunction and the regulatory role of microRNAs
Aryan, L., Medzikovic, L., Umar, S., & Eghbali, M. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00292-w · Cited by 30
“Insulin resistance results in impaired plasma membrane translocation of glucose transporter 4 (GLUT4), the primary transporter that is responsible for shuttling glucose into the cell as an energy source [76].”
BackgroundImpact of Gestational Diabetes Mellitus on Fetal Growth and Nutritional Status in Newborns
Karcz, K., & Królak-Olejnik, B. (2024) · Nutrients · doi:10.3390/nu16234093 · Cited by 25
Sun, J., Wang, J., Ma, W., Miao, M., & Sun, G. (2022) · Nutrients · doi:10.3390/nu14214626 · Cited by 25
Kokori, E., Olatunji, G. D., Aderinto, N., Muogbo, I., Ogieuhi, I. J., Isarinade, D. T., Ukoaka, B. M., Akinmeji, A., Ajayi, I., Ezenwoba, C., et al. (2024) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-024-00176-7 · Cited by 34
Anthocyanin: Potential tool for diabetes management and different delivery aspects
Sharma, S., Pandita, G., & Bhosale, Y. K. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.104170 · Cited by 33
An update of the consensus statement on insulin resistance in children 2010
Tagi, V. M., Samvelyan, S., & Chiarelli, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1061524 · Cited by 34
“The offspring risk of T2D is more closely associated with maternal than paternal diabetes (68).”
BackgroundKaminski, V. D. L., Michita, R. T., Ellwanger, J. H., Veit, T. D., Schuch, J. B., Riesgo, R. D. S., Roman, T., & Chies, J. A. B. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15593 · Cited by 30
“GDM does not only increases the risk of ASD, but also increases the risk of DM type 2, cardiovascular disorders in the offspring, and birth complications [133].”
BackgroundChen, L., & Zhu, Y. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01552-4 · Cited by 42
“Although the etiology and pathogenesis of GDM is not fully understood, most individuals with GDM appear to have β-cell dysfunction that occurs on a background of chronic insulin resistance [63, 64].”
Zhang, C., & Zhao, D. (2021) · Bioengineered · doi:10.1080/21655979.2021.1933678 · Cited by 25
“GDM is associated with the increased risk of cardiovascular diseases and type 2 diabetes both in the women and child [2].”
BackgroundLizárraga, D., & García-Gasca, A. (2021) · Epigenomes · doi:10.3390/epigenomes5020013 · Cited by 29
“hyperinsulinemia, and hypoglycemia [6].”
BackgroundMavroeidi, I., Manta, A., Asimakopoulou, A., Syrigos, A., Paschou, S. Α., Vlachaki, E., Nastos, C., Kalantaridou, S., & Peppa, Μ. (2024) · Nutrients · doi:10.3390/nu16030399 · Cited by 33
“…as the pregnancy progresses, a surge of hormones, including estrogen, progesterone, leptin, cortisol, placental lactogen, and placental growth hormones together promote a state As part of the normal response, maternal tissues such as muscle and fat become relatively insulin-resistant. of IR [3].”
BackgroundInfluentialTelomere erosion as a placental clock: From placental pathologies to adverse pregnancy outcomes
Kohlrausch, F. B., & Keefe, D. L. (2020) · Placenta · doi:10.1016/j.placenta.2020.06.022 · Cited by 30
Wang, N., Song, L., Sun, B., Peng, Y., Fei, S., Cui, J., Mi, Y., & Cui, W. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13113 · Cited by 29
“transporter-1 transports maternal circulating glucose to the fetal circulation in a concentration-dependent manner,(28) and in women with GDM-dysfunction, excessive glucose may be transported to the fetus and result in fetal hyperinsulinemia—which directly contributes to excessive fetal growth.(29) Therefore, placenta…”
BackgroundLiu, F., Sui, W., Zhou, Z., Mi, Y., He, T., Li, Z., Hong, Y., & Chen, F. (2021) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13578 · Cited by 29
Pharmaco-epi-genetic and patho-physiology of gestational diabetes mellitus (GDM): An overview
Shamsad, A., Kushwah, A. S., Singh, R., & Banerjee, M. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100086 · Cited by 38
Krause, B. J. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30470 · Cited by 25
“This is an important issue considering the high pre- valence of obesity in developing and developed countries and its strong relation with gestational diabetes (Plows et al., 2018) and PE (Staff, 2019).”
BackgroundInnervation of the pancreas in development and disease
Agerskov, R. H., & Nyeng, P. (2024) · Development · doi:10.1242/dev.202254 · Cited by 28
Inthavong, S., Jatavan, P., & Tongsong, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111666 · Cited by 37
“Simultaneously, pancreatic beta-cells may fail to adequately increase insulin production to meet the increased demand due to genetic factors, metabolic stress, and lipotoxicity [28,34,35].”
BackgroundZhao, Y., Gao, Q., Li, B., Wang, Y., & Wang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1177547 · Cited by 28
“Current studies have demonstrated that the occurrence and development of GDM is influenced by multiple factors, among which genetic, metabolic and environmental factors are important in the pathogenesis of GDM(5).”
BackgroundNew born macrosomia in gestational diabetes mellitus
Bernea, E. G., Uyy, E., Mihai, D. A., Ceauşu, I., Ionescu-Tirgoviste, C., Șuică, V. I., Ivan, L., & Antohe, F. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11646 · Cited by 33
“Physiological IR during pregnancy is necessary for fetal growth and when insulin secretion fails to compensate for IR, hyperglycaemia and GDM develops (6).”
BackgroundChen, H., Wang, S., Li, H., Zhou, X., Zhou, L.-W., Chen, C., Mansell, T., Novakovic, B., Saffery, R., Baker, P. N., et al. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109708 · Cited by 28
Self-citationChatzakis, C., Sotiriadis, A., Tsakmaki, E., Papagianni, M., Paltoglou, G., Dinas, K. D., & Mastorakos, G. P. (2021) · Nutrients · doi:10.3390/nu13072284 · Cited by 31
“Gestational diabetes mellitus d velops in women whose p ncreatic function is insufficient to overcome this pregnancy-associated insulin resistance, resulting in increased concentrations of blood glucose [41].”
BackgroundIwama, N., Sugiyama, T., Metoki, H., Saito, M., Hoshiai, T., Watanabe, Z., Tanaka, K., Sasaki, S., Sakurai, K., Ishikuro, M., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108377 · Cited by 26
Roverso, M., Dogra, R., Visentin, S., Pettenuzzo, S., Cappellin, L., Pastore, P., & Bogialli, S. (2022) · Mass Spectrometry Reviews · doi:10.1002/mas.21777 · Cited by 28
Late Cognitive Consequences of Gestational Diabetes to the Offspring, in a New Mouse Model
Sousa, R. A. L. D., de Lima, E. V., da Silva, T. P., Souza, R. V., Figueiredo, C. P., Passos, G. F., & Clarke, J. R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1624-0 · Cited by 25
Ye, Y., Wu, P., Wang, Y., Yang, X., Ye, Y., Yuan, J., Liu, Y., Song, X., Yan, S., Wen, Y., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110039 · Cited by 30
Machine learning based model for the early detection of Gestational Diabetes Mellitus
Zaky, H., Fthenou, E., Srour, L., Farrell, T. J., Bashir, M., Hajj, N. E., & Alam, T. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-02947-3 · Cited by 34
“Insulin resistance plays a crucial role in the development of GDM, where insulin resistance causes impaired normal glucose metabolism and contributes to hyperglycemia during pregnancy [51].”
Xuemei, L., Qiu, S., Chen, G., & Liu, M. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22904 · Cited by 25
Sex and Gender Related Differences in Diabetic Kidney Disease
Sridhar, V. S., Yau, K., Benham, J. L., Campbell, D. J. T., & Cherney, D. Z. I. (2022) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2022.04.007 · Cited by 26
Azeez, T. A., Abo-Briggs, T., & Adeyanju, A. S. (2021) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_301_21 · Cited by 38
“The ADA and ACOG recommend that any of the approaches (either the one‑step approach or the two‑step approach) could be adopted in making a diagnosis of GDM.[23] In the past, WHO had recommended a set of criteria, often tagged the ‘WHO 1999 criteria,’ for the diagnosis of GDM.”
BackgroundInfluentialQué hay acerca de las personas en la ciencia regional
Hägerstrand, T. (1991) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 24
Zhang, Z., Qian, X., Chen, Y., Sui, L., Jiang, L., Shen, Q., Li, M.-Y., Li, G., & Wang, Q. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03737-1 · Cited by 23
“GDM contributes to the occurrence of preeclampsia [3], gestational hypertension [4], macrosomia [5] and pre-”
BackgroundMetformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question
Tocci, V., Mirabelli, M., Salatino, A., Sicilia, L., Giuliano, S., Brunetti, F. S., CHIEFARI, E. D., Sarro, G. D., FOTI, D. P., & Brunetti, A. (2023) · Pharmaceuticals · doi:10.3390/ph16091318 · Cited by 39
“Therefore, Therefore, the liver does not seem to be the main driver of glucose intolerance in women with GDM [19]. the liver does not seem main driver of glucose intolerance in women with GDM [19].”
BackgroundContreras‐Duarte, S., Carvajal, L., Garchitorena, M. J., Subiabre, M., Fuenzalida, B., Cantin, C., Farías, M., & Leiva, A. (2020) · Nutrients · doi:10.3390/nu12020506 · Cited by 25
“It is well documented that newborns from women with GDM present macrosomia as a consequence of hyperinsulinemia [69,70].”
BackgroundNanocarriers targeting the diseases of the pancreas
Demirtürk, N., & Bilensoy, E. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.11.006 · Cited by 24
Gut Microbiota across Normal Gestation and Gestational Diabetes Mellitus: A Cohort Analysis
Dualib, P. M., Taddei, C. R., Fernandes, G. D. R., Carvalho, C. R. D. S., Sparvoli, L. G., da Silva, I. T., Mattar, R., Ferreira, S. R. G., Dib, S. A., & de Almeida-Pititto, B. (2022) · Metabolites · doi:10.3390/metabo12090796 · Cited by 27
“As far as GDM is concerned, heterogeneous data linking the gut microbiota with GDM across the gestation trimesters have been found [12,13].”
BackgroundRaczkowska, B. A., Mojsak, P., Rojo, D., Telejko, B., Paczkowska‐Abdulsalam, M., Hryniewicka, J., Zielińska-Maciulewska, A., Szelachowska, M., Górska, M., Barbas, C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770240 · Cited by 27
“Women who had GDM have an elevated risk to develop diabetes mellitus type 2 (T2DM) or cardiovascular diseases, as well as obesity or hyperlipidemia in later life (Plows et al., 2018).”
BackgroundPerinatal outcomes in twin pregnancies complicated by gestational diabetes
Dave, E. D., Bodnar, L. M., Vani, K., & Himes, K. P. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100396 · Cited by 26
miR-520h inhibits cell survival by targeting mTOR in gestational diabetes mellitus
Wen, J., & Bai, X. (2021) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5389 · Cited by 25
“In recent years, it has been generally believed that the pathogenesis of GDM is a complex issue that is caused by multiple factors, such as inflammatory factors, insulin resistance, dysfunction of islet β-cells, genetics, and environment (Plows et al., 2018).”
BackgroundThe effect of ambient ozone exposure on three types of diabetes: a meta-analysis
Yu, S., Zhang, M., Zhu, J., Xu, Y., Bigambo, F. M., Snijders, A. M., Wang, X., Hu, W., Lv, W., & Xia, Y. (2023) · Environmental Health · doi:10.1186/s12940-023-00981-0 · Cited by 24
Lim, S. S., Takele, W. W., Vesco, K. K., Redman, L. M., Hannah, W., Bonham, M. P., Chen, M., Chivers, S. C., Fawcett Andrea, J., Grieger, J. A., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00366-x · Cited by 37
“This may be because women with a prior history of GDM have impaired beta-cell compensatory response during pregnancy and persistent or ongoing decline in insulin sensitivity post-GDM pregnancy 11 .”
Diboun, I., Ramanjaneya, M., Majeed, Y., Ahmed, L., Bashir, M., Butler, A. E., Abou‐Samra, A., Atkin, S. L., Mazloum, N. A., & Elrayess, M. A. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02531-5 · Cited by 27
Proteomics Studies in Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
Sriboonvorakul, N., Hu, J., Boriboonhirunsarn, D., Ng, L. L., & Tan, B. K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102737 · Cited by 27
Sun, C. M., Shen, J., Fang, R., Huang, H., Lai, Y., Hu, Y., & Zheng, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1393883 · Cited by 28
“Compared to diabetes, GDM can cause more complications during pregnancy (4, 5).”
Thyroid autoimmunity and pregnancy in euthyroid women
Kyrilli, A., Unuane, D., & Poppe, K. G. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101632 · Cited by 28
“Therefore, a link with TAI seems to be plausible [65,66].”
InfluentialChatzakis, C., Eleftheriades, A., Demertzidou, E., Dinas, K. D., Vlahos, N., Sotiriadis, A., & Eleftheriades, M. I. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110913 · Cited by 30
Niu, Z., Habre, R., Yang, T., Grubbs, B. H., Eckel, S. P., Toledo‐Corral, C. M., Johnston, J., Dunton, G. F., Lurvey, N., Al-Marayati, L. A., et al. (2023) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2023.100575 · Cited by 35
Recent advancements on novel approaches of insulin delivery
Karmakar, S., Bhowmik, M., Laha, B., & Manna, S. (2023) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2023.100253 · Cited by 31
A Critical Review of Proteomic Studies in Gestational Diabetes Mellitus
Zhou, T., Huang, L., Wang, M., Chen, D., Chen, Z., & Jiang, S. (2020) · Journal of Diabetes Research · doi:10.1155/2020/6450352 · Cited by 25
“It is known that the high levels of hormones, such as progesterone and placental lactogen, may promote insulin resistance and result in hyperglycemia during pregnancy [3].”
BackgroundBiological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma
Liu, Z., Hayashi, H., Matsumura, K., Uemura, N., Shiraishi, Y., Sato, H., & Baba, H. (2023) · Cancers · doi:10.3390/cancers15020498 · Cited by 24
Choi, Y., Nagel, E., Kharoud, H., Johnson, K. E., Gallagher, T. T., Duncan, K. M., Kharbanda, E. O., Fields, D. A., Gale, C. A., Jacobs, K., et al. (2022) · Nutrients · doi:10.3390/nu14030667 · Cited by 26
“history of insulin resistance and/or diabetes [2,3].”
BackgroundInfluentialHashmi, I. A., Al-Sabti, H. A., Omari, O. A., Nasiri, Y. A., & Khalaf, A. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04684-1 · Cited by 23
Wu, X., Lin, D., Li, Q., Cai, J., Huang, H., Xiang, T., & Tan, H. (2023) · Aging · doi:10.18632/aging.204973 · Cited by 23
Fougner, S. L., Vanky, E., Løvvik, T. S., & Carlsen, S. M. (2021) · PLOS ONE · doi:10.1371/journal.pone.0254895 · Cited by 23
“Hence, factors increasing insulin resistance, such as advanced maternal age and increased body mass index (BMI), are known risk factors for the development of GDM [1,2].”
BackgroundGestational diabetes mellitus: genetic factors, epigenetic alterations, and microbial composition
Lizárraga, D., Gómez‐Gil, B., García-Gasca, T., Ávalos-Soriano, A., Casarini, L., Salazar-Oroz, A., & García-Gasca, A. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02176-y · Cited by 32
Tang, Z., Luo, T., Huang, P., Luo, M. Y., Zhu, J., Wang, X., Lin, Q., He, Z., Gao, P., & Liu, S. (2021) · Food & Function · doi:10.1039/d1fo02714j · Cited by 23
Papaetis, G. S. (2021) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2021.105314 · Cited by 25
Effectiveness of Scutellaria baicalensis Georgi root in pregnancy-related diseases: A review
Fang, D., Zheng, C., & Ma, Y. (2022) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2022.09.005 · Cited by 24
Suzuki, K., Hatzikotoulas, K., Southam, L., et al. (2023) · medRxiv · doi:10.1101/2023.03.31.23287839 · Cited by 21
Recent progress in metabolic reprogramming in gestational diabetes mellitus: a review
Xie, Y., Lin, S., Xie, B., & Zhao, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1284160 · Cited by 25
Rassie, K. L., Giri, R., Melder, A., Joham, A. E., Mousa, A., & Teede, H. J. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055257 · Cited by 25
A new marker predicting gestational diabetes mellitus: First trimester neutrophil/lymphocyte ratio
Şahin, M., Oğuz, A., Tüzün, D., et al. (2022) · Medicine · doi:10.1097/md.0000000000030511 · Cited by 21
“[2] Inflammation is 1 of the main components of natural immunity in humans.”
BackgroundDietary potato intake and risks of type 2 diabetes and gestational diabetes mellitus
Guo, F., Zhang, Q., Jiang, H., He, Y., Li, M., Ran, J., Lin, J., Tian, L., & Ma, L. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.04.039 · Cited by 24
Stacked Ensemble-Based Type-2 Diabetes Prediction Using Machine Learning Techniques
Rahim, M. A., Hossain, M. A., Hossain, M. N., Shin, J., & Yun, K. S. (2023) · Annals of Emerging Technologies in Computing · doi:10.33166/aetic.2023.01.003 · Cited by 27
“The symptoms of gestational diabetes are observed in pregnant women and usually go away after childbirth [3].”
Serum C18:1-Cer as a Potential Biomarker for Early Detection of Gestational Diabetes
Juchnicka, I., Kuźmicki, M., Zabielski, P., Kretowski, A. J., Błachnio-Zabielska, A. U., & Szamatowicz, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020384 · Cited by 25
“The data show that the main pathophysiological dysfunction in GDM is the increasing insulin resistance and insufficient insulin compensation, usually as a result of the β-cell impairment [1,22].”
BackgroundSabarathinam, S., Jayaraman, A., & Venkatachalapathy, R. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106674 · Cited by 22
Ilari, L., Piersanti, A., Göbl, C. S., Burattini, L., Kautzky‐Willer, A., Tura, A., & Morettini, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.789219 · Cited by 26
“Therefore, determination of factors influencing the development of T2DM may also shed light on GDM and potentially accelerate opportunities for prevention and treatment (Plows et al., 2018).”
BackgroundBrunner, K., Linder, T., Klaritsch, P., Tura, A., Windsperger, K., & Göbl, C. S. (2025) · Current Diabetes Reports · doi:10.1007/s11892-025-01585-3 · Cited by 33
“Women with a history of GDM are at a significantly higher risk of developing type 2 diabetes and experiencing gestational insulin resistance and hyperglycemia in sub - sequent pregnancies [67].”
The Impact of Gestational Diabetes Mellitus on Human Milk Metabolic Hormones: A Systematic Review
Suwaydi, M. A., Zhou, X., Perrella, S. L., Wlodek, M. E., Lai, C. T., Gridneva, Z., & Geddes, D. T. (2022) · Nutrients · doi:10.3390/nu14173620 · Cited by 25
“Dysregulation of this metabolic adaptation causes gestational diabetes mellitus (GDM) [5], which is associated with substantial short- and long-term risks for the infant [6].”
BackgroundThe Impact of Coexisting Gestational Diabetes Mellitus on the Course of Preeclampsia
Pankiewicz, K., Szczerba, E., Fijałkowska, A., Sierdziński, J., Issat, T., & Maciejewski, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216390 · Cited by 29
“Pro-inflammatory cytokines secreted in adipose tissue in GDM (such as TNFα, IL-1β, IL-6) impair insulin signaling and inhibit insulin release from β-cells; however, this relationship is complex and not straightforward, because there are studies reporting that GDM placentae secrete fewer pro-inflammatory cytokines than…”
BackgroundExtracellular Vesicles as Biomarkers of Pregnancy Complications
Popova, A. K., Vashukova, E. S., Illarionov, R. A., Maltseva, A. R., Pachuliia, O. V., Postnikova, T. B., & Glotov, A. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211944 · Cited by 30
Gao, S., & Wang, J. (2023) · Protein & Cell · doi:10.1093/procel/pwad029 · Cited by 22
“The diagnoses of these pregnant diseases constantly depend on the parameters that tested after 20 weeks of pregnancy (Sibai, 2003; Weinert, 2010), but there is not yet a cure or an efficacious prevention strategy for those pregnant diseases when it came to late pregnancy (Plows et al., 2018).”
BackgroundJiang, Y., Wei, L., Zhang, H., Chen, Y., Gao, P., Zhang, J., Zhou, X., Zhu, S., Du, Y., Fang, C., et al. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s385774 · Cited by 22
“12 Besides, miR-96 was significantly down-regulated in GDM, resulting in decreased insulin concentration and cell viability.”
BackgroundInfluentialGómez, A. Y., Ramos, P., & Bartha, J. L. (2022) · Nutrients · doi:10.3390/nu14142954 · Cited by 26
“Currently, the ADA, the WHO, the FIGO and the Endocrine Society recommend the diagnosis of GDM using the IADPSG criteria [1], which were developed based on the results of the HAPO study [5].”
BackgroundMethodInfluentialGalectins: Important Regulators in Normal and Pathologic Pregnancies
Chen, M., Shi, J., Zheng, Z., Lin, Z., Li, M., & Shao, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710110 · Cited by 24
“Effects on the fetus include fetal malformations and fetal growth restriction [162].”
BackgroundErbetta, K. F., Almeida, J., & Waldman, M. R. (2022) · SSM - Population Health · doi:10.1016/j.ssmph.2022.101176 · Cited by 23
Li, J., Li, Y., Zhou, X., Wei, L., Zhang, J., Zhu, S., Zhang, H., Gao, X., Sharifu, L. M., Wang, S., et al. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00533-4 · Cited by 28
Yue, S., Thi, V. T. K., Dung, L. P., Nhu, B. T. H., Kestelyn, E., Trọng, T. Đ., Thanh, L. Q., & Hirst, J. E. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04533-1 · Cited by 25
“Background Gestational diabetes mellitus (GDM) is the new onset of glucose intolerance during pregnancy and affects around 15% of pregnancies worldwide, equivalent to 21 million births annually [1, 2].”
BackgroundMcElwain, C. J., & McCarthy, C. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.04.037 · Cited by 21
Qiu, S., Wu, X., Wu, Q., Jin, X., Li, H., & Roy, R. (2023) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-023-04586-8 · Cited by 25
Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus
Zhang, L., Bi, L., Wang, W., Miao, S., Zhou, S., Cheng, X., Zhu, J., & Liu, C.-M. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211049614 · Cited by 22
Ural, A., & Beji, N. K. (2020) · Psychology Health & Medicine · doi:10.1080/13548506.2020.1856390 · Cited by 25
“During a ten-year follow-up, the risk of type 2 diabetes in women with GDM may be as high as 70% (Gilbert et al., 2019; Plows et al., 2018; Rono et al., 2014).”
BackgroundJiang, Y., Zhu, H., Chen, Z., Yu, Y., Guo, X., Chen, Y., Yang, M., Chen, B.-W., Sagnelli, M., Xu, D. Q., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.844707 · Cited by 28
“Currently, there are no definitive treatments for GDM except lifestyle change and limited insulin therapy (5).”
BackgroundLewandowska, M. (2021) · Nutrients · doi:10.3390/nu13030801 · Cited by 28
“Family— Diabetes mellitus in the father [35,36] was assessed in the three following categories: (1) diabetes in the father; (2) diabetes in the family but not in the father; (3) no diabetes in the family.”
BackgroundDietary Impacts on Gestational Diabetes: Connection between Gut Microbiome and Epigenetic Mechanisms
Bankole, T., Winn, H. N., & Li, Y. (2022) · Nutrients · doi:10.3390/nu14245269 · Cited by 25
“According to the International Diabetes Federation (IDF), GDM has a global prevalence, with the highest prevalence in the Middle East and North Africa [1,2].”
Smith‐Jackson, K., & Harrison, R. A. (2022) · Immunological Reviews · doi:10.1111/imr.13169 · Cited by 24
“143).”
Metadata
- Authors
- Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H.
- Affiliations
- University of Southern California (US)
- University of Auckland (NZ)
- University of Leicester (GB)
- Corresponding author
- Vickers, Mark H
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-26
- Volume
- 19
- Issue
- 11
- Pages
- 3342
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274679
- OpenAlex
- W2898266729
- Cited by
- 1,874
- References
- 175
- Citations by year
- 2026: 277 · 2025: 298 · 2024: 319 · 2023: 307 · 2022: 295 · 2021: 221 · 2020: 122 · 2019: 33
- FWCI
- 15.21
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Leicester Research Archive (University of Leicester) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- gestational diabetes mellitus, pathophysiology, hyperglycemia in pregnancy, impaired glucose tolerance, beta-cell dysfunction, insulin resistance, maternal obesity, type 2 diabetes risk, macrosomia, cardiovascular risk, GDM prevention, insulin therapy, lifestyle intervention
- MeSH terms
- Adipose Tissue, Animals, Female, Glucose, Humans, Insulin Resistance, Pregnancy, Risk Factors, Diabetes, Gestational, Oxidative Stress, Leptin, Insulin-Secreting Cells, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.